2238 Trabulsi, Edouard - Thomas Jefferson University - Thomas Jefferson University
ext273

Edouard Trabulsi, MD

Contact Dr. Trabulsi

1025 Walnut Street
Suite 1112
Philadelphia, PA 19107

(215) 955-6961
(215) 923-1884 fax

Most Recent Peer-reviewed Publications

  1. Treatment of Exophytic Renal Cancer Smaller than 3 cm: Surgery versus Active Surveillance
  2. Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy
  3. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: Results of a multicenter phase II study with molecular correlates of response and toxicity
  4. High dose rate brachytherapy boost for prostate cancer: A systematic review
  5. A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer
  6. Characterization of renal masses with harmonic and subharmonic contrast-enhanced ultrasound
  7. Surgical suturing training with virtual reality simulation versus dry lab practice: an evaluation of performance improvement, content, and face validity
  8. Implementing Hexaminolevulinate HCl Blue LightCystoscopy: A Nursing Perspective
  9. The effects of fatigue on robotic surgical skill training in Urology residents
  10. Predictors of positive surgical margins after radical prostatectomy at a single institution: Preoperative and pathologic factors, and the impact of surgeon variability and technique on incidence and location
  11. Impact of NADiA ProsVue PSA slope on secondary treatment decisions after radical prostatectomy
  12. Patterns of care for elderly men diagnosed with favorable-risk prostate cancer from 2004 to 2008 : A population-based analysis
  13. Identifying barriers to patient acceptance of active surveillance: content analysis of online patient communications.
  14. Targeting cell cycle and hormone receptor pathways in cancer
  15. Pharmacologic inhibition of Jak2-Stat5 signaling by Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer
  16. Evolution of advanced technologies in prostate cancer radiotherapy
  17. Percutaneous cryoablation for recurrent low grade renal cell carcinoma after failed nephron-sparing surgery
  18. STAT5A/B gene locus undergoes amplification during human prostate cancer progression
  19. The dilemma of a rising prostate-specific antigen level after local therapy: What are our options?
  20. Multimodality therapy for patients with high-risk prostate cancer: Current status and future directions
0